Advertisement
Document › Details
Polyplus-transfection S.A.. (7/6/18). "Press Release: Polyplus-transfection Launches New Advanced System for Transient Protein Expression in CHO cells". Strasbourg.
Organisation | Polyplus-transfection S.A. | |
Group | Sartorius (Group) | |
Product | FectoCHO™ Expression System | |
Product 2 | CHO cell line | |
Polyplus-transfection SA, a biotechnology company offering innovative solutions for the delivery of nucleic acids for research, bioproduction and therapeutic applications, announces the launch of its FectoCHO™ Expression System. The new system is designed for enhanced protein production in CHO cells, showing outstanding protein yields even at low DNA amounts.
The growing need for various recombinant antibodies and other proteins in the biotechnology and biopharma sectors requires an efficient and flexible bioproduction system. “Transient expression” is a technology commonly use to introduce nucleic acids into production cell line. Current available transfection solutions are limited due to insufficient transfection efficiency resulting in low protein productivity, especially when applied to CHO (Chinese Hamster Ovary) cells.
“To overcome this issue, we have developed an advanced transient expression system, the FectoCHO™ Expression System,” stated Dr. Patrick Erbacher, CSO of Polyplus-transfection. “Our new system shows amazing protein production yields in various CHO cells.”
High productivity – even at small DNA amounts
The FectoCHO™ Expression System consists of three synergistically acting components:
FectoCHO™ CD Expression Medium
FectoPRO® Transfection Reagent
FectoPRO® Expression Booster
The FectoCHO™ CD Expression Medium is a chemically defined cell culture medium, optimized for transient gene expression. It enables fast, effortless adaptation and cultivation of various strains of CHO cells, such as CHO-K1, CHO-S and ExpiCHO™-S. The FectoPRO® Transfection Reagent, when combined with the expression medium, achieves amazing protein yields, also for small amounts of DNA transfected. The FectoPRO® Expression Booster enhances gene expression levels and boosts protein production in various CHO cells. The yields are up to four times higher compared to competitors’ expression systems.
Excellent reproducibility
FectoCHO™ Expression System components are manufactured and formulated using a highly controlled production process. This ensures excellent lot-to-lot reproducibility – for greater reliability and higher quality in bioproduction. “Increased productivity and excellent reproducibility make our new expression system an affordable and reliable solution for bioproduction processes,” said Patrick. “The system is perfectly suited to protein and antibody production – even in therapeutic applications.”
Want to know more about FectoCHO™ Expression system
About Polyplus-transfection
Polyplus-transfection SA is a biotechnology company founded in 2001 that develops, markets and sells innovative solutions for the in vivo, in vitro and ex vivo delivery of nucleic acids in research, bioproduction and therapeutics. Located close to the University of Strasbourg in Eastern France, Polyplus-transfection has been ISO 9001-certified since 2002 and supplies its proprietary range of reagents for the transfection of genes and oligonucleotides. Polyplus reagents are involved in a growing number of clinical trials worldwide. In addition, Polyplus-transfection holds a broad estate of patents and licenses in the field of nucleic acid delivery.
[Picture]
The synergistic combination of FectoPRO® reagent and FectoCHO™ CD medium outperforms its main competitor in CHO-K1 cells. © Polyplus-transfection SA
[Picture]
FectoCHO™ expression system outperforms ExpiCHO™ expression system in terms of protein production kinetics in ExpiCHO-S cells. © Polyplus-transfection SA
Press Contact
Polyplus-transfection SA
Géraldine Guérin-Peyrou
phone: +33 (0)3 90406186
e-mail: ggp@polyplus-transfection.com
Record changed: 2023-06-05 |
Advertisement
More documents for Sartorius (Group)
- [1] Refeyn Ltd.. (10/2/23). "Press Release: Refeyn Announces Appointment of New CEO". Oxford....
- [2] Sartorius AG. (9/28/23). "Press Release: Sartorius Forms Partnership with Sparta Biodiscovery on Novel Nanoparticle Analysis Platform". Göttingen....
- [3] Sartorius AG. (8/17/23). "Press Release: Sartorius and Repligen Corporation Launch Integrated System with Biostat STR and XCell ATF for Upstream Process Intensification". Göttingen....
- [4] Helmholtz Zentrum München (Helmholtz Munich). (8/7/23). "Press Release: Life Science Factory to Open a New Location at Helmholtz Munich in 2024". Göttingen & Munich....
- [5] Sartorius AG. (8/3/23). "Press Release: Florian Funck Appointed CFO of Sartorius. New CFO to Take Over as of April 2024". Göttingen....
- [6] Life Science Factory Management GmbH. (7/24/23). "Pressemitteilung: Tatjana Kasper wird neue Geschäftsführerin". Göttingen....
- [7] Waters Corporation. (6/5/23). "Press Release: Waters and Sartorius Expand Collaboration to Deliver Comprehensive Bioanalytics for Downstream Biomanufacturing". Milford, MA & Göttingen....
- [8] va-Q-tec AG. (4/26/23). "Press Release: Sartorius and va-Q-tec Announce a Long-term Partnership for the Joint Development of Innovative Transport Systems for the Biopharmaceutical Industry". Würzburg & Göttingen....
- [9] Sartorius. (3/31/23). "Press Release: Sartorius to Acquire Polyplus. France-based Polyplus Is a Provider of Innovative Upstream Technologies for Cell and Gene Therapies". Göttingen....
- [10] Life Science Valley Ventures Management GmbH. (2/13/23). "Press Release: New Fund for Promoting Life Science Start-ups in Lower Saxony". Göttingen....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top